The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×

Sections

Guidelines and Classification: A Spectrum of Use | Epidemiology of Late-Life Substance Use | Correlates and Consequences of Substance Use Problems | Screening and Diagnosis of Substance Use Problems | Use of Biological Markers for Screening | Treatments for Substance Use Problems | Medical and Psychiatric Comorbidity | Conclusion and Future Directions | References

Excerpt

Alcohol and drug use disorders are associated with an array of negative physical and mental health outcomes that are exacerbated with advancing age, such as functional and cognitive decline, compromised immune function, and depression. However, much remains to be learned about the correlates and consequences of substance use among older adults. Substance misuse in later life, which encompasses misuse of alcohol and illicit, prescription, and over-the-counter (OTC) drugs, has been referred to as both an “invisible” and “emerging” epidemic (Sorocco and Ferrell 2006; Yarnell et al. 2020). Epidemiological work, which has focused on younger populations, demonstrates that beginning in the middle to late 20s, overall rates of alcohol and illicit drug use begin to decline, with most older adults reporting no substance use. Nevertheless, changes in demographic and cohort trends suggest that substance misuse in later life is a pressing public health matter and that older adults represent a group in growing need of specialized substance treatment programs and services (Chhatre et al. 2017; Grant et al. 2017).

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.
  • Institutional Login
  • Sign in via OpenAthens
  • Register for access
  • Please login/register if you wish to pair your device and check access availability.

    Not a subscriber?

    Subscribe Now / Learn More

    PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

    Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).